Rapid, instrument-free diagnostics at the point-of-need
CHEMELEON SENSING
Chemeleon has created a novel platform technology for rapid, accurate, and affordable diagnostics that are capable of detecting a broad range of analytes including drugs, proteins, and viruses. This proprietary, sample-to-answer format provides a colorimetric readout in minutes, visible to the naked eye, without the need for any readers, instruments, equipment, or training, providing truly decentralized testing that can enable clinicians to extend the point-of-care beyond the clinic.
Medical Solutions
Acute Myocardial Infarction Detection
As the first application of Chemeleon’s platform technology, we have developed a colorimetric acute myocardial infarction (AMI) diagnostic that can be administered without the need for instrumentation, providing clinicians with a visible yes or no read-out in under 2 mins.
Delayed detection of AMI can lead to worsened patient outcomes, increased morbidity, and substantially higher healthcare costs for millions of individuals each year. Our rapid and precise diagnostic not only improves survival rates and reduces complications but also helps streamline emergency department workflows by enabling quick triage and clearing ED waiting areas, allowing healthcare providers to focus on timely intervention and treatment.
AMI detection in 2 minutes
Minimal training required
Instrument-free testing
Partner With Us
We welcome inquiries from all interested collaborators and investors who share our goal to improve early detection with accessible, affordable, decentralized, and advanced point-of-care / point-of-need diagnostics. To begin a discussion and learn more about how we can achieve our goals together, please reach out to us via our contact form.
Partnering Institutions
